Delivery Order SPE2DB20D3101-SPE2DB24FRCD6
Award Date 2/23/24
Potential Completion Date 2/26/24
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The $34,971.79 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S over a period ending on April 16, 2024. The contract, valued at $2,213.85, was awarded by the Defense Logistics Agency (DLA) under a Firm Fixed Price delivery order. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the purchase of NARCAN 4 MG NASAL SPRAY 2S. The $7,350.25 firm fixed price contract has a completion date of January 31, 2023 and is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,449.12 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,221.63 contract is for the supply of NARCAN 4 MG NASAL 2S, a critical medical product, under a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of NARCAN 4 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,344.97, is a firm fixed-price delivery order with a completion date of January 30, 2023. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
- This federal contract award, valued at $20,366.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NARCAN 4 MG NASAL SPRAY 2S. This is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The $2,354.53 firm-fixed-price contract has an ultimate completion date of January 25, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY to the Defense Logistics Agency (DLA), a defense agency. The $4,039.26 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 17, 2024, with a final completion date of October 18, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose, to the Defense Logistics Agency (DLA). The $1,696.75 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 3, 2024. The contract has an ultimate completion date of December 4, 2024 and is not designated with any set-aside requirements. Amerisourcebergen holds a...